ENDRA Life Sciences (NDRA) Free Cash Flow Growth (1y) (2017 - 2026)
ENDRA Life Sciences (NDRA) Free Cash Flow Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 51.58% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 16.06% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -173.96% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 87.85% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 23.29% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 112.68% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -21.08% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 33.01% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -42.16% |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - | 16.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.71% |
| Mar 31, 2026 | 14.56% |
| Dec 31, 2025 | -6.33% |
| Sep 30, 2025 | 29.76% |
| Jun 30, 2025 | 46.26% |
| Mar 31, 2025 | 39.65% |
| Dec 31, 2024 | 30.52% |
| Sep 30, 2024 | 36.23% |
| Jun 30, 2024 | 8.65% |
| Mar 31, 2024 | 14.31% |
| Dec 31, 2023 | 30.24% |
| Sep 30, 2023 | 20.32% |
| Jun 30, 2023 | 33.17% |
| Mar 31, 2023 | 20.52% |
| Dec 31, 2022 | -17.89% |
| Sep 30, 2022 | -18.75% |
| Jun 30, 2022 | -21.27% |
| Mar 31, 2022 | -7.40% |
| Dec 31, 2021 | -24.08% |
| Sep 30, 2021 | -29.47% |